Narcolepsy Management Guidelines

Diagnostic Approach

The American Geriatrics Society recommends establishing onset, frequency, and duration of sleepiness as well as any episodes of remission in patients with suspected narcolepsy 1
Assess for key symptoms including excessive daytime sleepiness, sleep paralysis, and hypnagogic/hypnopompic hallucinations in patients with suspected narcolepsy 1
The American Geriatrics Society suggests using standardized assessment tools such as the Epworth Sleepiness Scale (ESS) to quantify sleepiness in patients with narcolepsy 1
Overnight polysomnography (PSG) followed by multiple sleep latency test (MSLT) is required for diagnosis of narcolepsy, with MSLT diagnostic criteria including mean sleep latency of 8 minutes or less and presence of REM sleep on 2 or more naps 1

The American Geriatrics Society recommends modafinil as the first-line treatment for excessive daytime sleepiness in patients with narcolepsy, with a starting dose of 100 mg once upon awakening in the morning and a typical dose range of 200-400 mg per day 1, 2, 3
Sodium oxybate improves both daytime sleepiness and cataplexy in patients with narcolepsy 3

The American Geriatrics Society recommends sodium oxybate as the first-line treatment for cataplexy in patients with narcolepsy, administered as a liquid in two divided doses at night 3
Antidepressants that inhibit reuptake of serotonin and/or norepinephrine, such as tricyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), and serotonin and norepinephrine reuptake inhibitors (SNRIs), are alternative treatments for cataplexy in patients with narcolepsy 3

The American Geriatrics Society recommends more frequent follow-up when starting medications or adjusting doses in patients with narcolepsy, with monitoring for adverse effects of stimulants and use of the ESS to monitor subjective sleepiness and treatment response at each visit 3

Narcolepsy is a lifelong disorder requiring ongoing management, and primary care physicians should refer to a sleep specialist when narcolepsy is suspected or the cause of sleepiness is unknown 3
In elderly patients, medications should be started at lower doses and titrated more gradually 2, 4

The American Academy of Sleep Medicine recommends modafinil as first-line treatment for excessive daytime sleepiness in narcolepsy, but this addresses only the sleepiness component, not REM intrusion symptoms, with a recommendation based on evidence from clinical sleep medicine 5, 6

Tricyclic antidepressants, SSRIs, venlafaxine, and reboxetine are used to treat cataplexy, hypnagogic hallucinations, and sleep paralysis by suppressing REM sleep, though adequate scientific evidence for these agents remains limited, as suggested by the Journal of the American Geriatrics Society 7
Sodium oxybate improves daytime sleepiness as well as cataplexy, and may be used to treat disrupted nocturnal sleep, hypnagogic hallucinations, and sleep paralysis, according to the Journal of the American Geriatrics Society 7
The American Academy of Sleep Medicine strongly recommends modafinil as first-line treatment for excessive daytime sleepiness in narcolepsy, but notes that this does not address REM intrusion symptoms, with guidance from the American Academy of Sleep Medicine 5, 6

For isolated hypnagogic hallucinations and sleep paralysis without significant daytime sleepiness, start with SSRIs or other REM-suppressant antidepressants, as recommended by the Journal of the American Geriatrics Society 7
For narcolepsy with both excessive daytime sleepiness and REM intrusion symptoms, first-line treatment is sodium oxybate for comprehensive symptom control, according to the Journal of the American Geriatrics Society 7
For excessive daytime sleepiness alone, use modafinil or other psychostimulants, but recognize these will not address hypnagogic hallucinations or sleep paralysis, with guidance from the American Academy of Sleep Medicine 5, 6

More frequent follow-up is necessary when starting medications or adjusting doses, monitoring for adverse effects, as recommended by the Journal of the American Geriatrics Society 7
Use the Epworth Sleepiness Scale to monitor subjective sleepiness and treatment response at each visit, as suggested by the Journal of the American Geriatrics Society 7